About
Dr. Glass is the Co-founder of Advantia Health. He has an extensive background as both a thought leader and experienced practitioner in ambulatory anesthesia and the pharmacology of analgesics. Prior to Advantia, Dr. Glass was Professor and Chairman of the Department of Anesthesiology at the State University of New York at Stony Brook. Throughout his career, he has been intimately involved in the growth of ambulatory surgery, both through his research and through his roles on the Board of the Society for Ambulatory Anesthesia (SAMBA), where he was also President in 2010. In 2015, Dr. Glass received the SAMBA Distinguished Service Award, the highest honor bestowed by SAMBA. Prior to Stony Brook, Dr. Glass pursued an academic career in anesthetic pharmacology which led to his appointment as Professor with Tenure at Duke University Medical Center in Durham, North Carolina. Nearly all of the SAFE (short-acting, fast-emergence) drugs in use today were studied and made popular in ambulator
Position in the VCSift Database
- • 2,540 investors hold the Co-Founder role in VCSift. Peter Glass is one of them.
- • 1,381 investors are based in Washington, District of Columbia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Washington, US
Contact Information
Find more investors like Peter
Search Investors